Digital Pharmacist
OCTOBER 25, 2023
November is American Diabetes Month – a time to come together to spread awareness about diabetes prevention and management. Pharmacies play a crucial role in healthcare, making them ideal partners in promoting awareness and education during this month. In this blog post, we’ll explore key ways pharmacies can actively participate in American Diabetes Month.
Pharmacy Times
OCTOBER 27, 2023
Pharmacists’ pharmacotherapeutic expertise helps them advocate for their patients and assist providers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
OCTOBER 26, 2023
Researchers assessed the reproducibility of at-home CGM acquisitions with mixed meal tolerance tests among patients with CF-related diabetes who were not treated with insulin.
STAT
OCTOBER 27, 2023
Prime Medicine said Friday it successfully used a new, ultra-versatile form of genetic surgery called prime editing to edit liver cells in monkeys. The results, presented at the European Society of Gene & Cell Therapy meeting in Brussels, are a major step for a technology that could transform treatment of numerous diseases. “I think the big celebration here is we’re showing, in primates, for the company, that we have a delivery system that is working and is safe,” said J
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Fierce Healthcare
OCTOBER 26, 2023
The approval of Leqembi by the Food and Drug Administration marks an exciting turning point for Alzheimer’s disease. | The approval of Leqembi by the FDA marks an exciting turning point for Alzheimer’s disease. There are big questions around costs, access, risk and efficacy in certain populations. The most urgent, overarching question is: How can we find patients who will benefit from the drug before their condition progresses outside of the treatment window?
Pharmacy Times
OCTOBER 23, 2023
Compared to endocrine therapy alone, the combination of ribociclib and endocrine therapy lowered the risk of cancer recurrence in patients with early breast cancer by 25.2%.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 25, 2023
Alison Buttenheim was floored by a sign she saw in her doctor’s office when she went to get the first jab of the two-dose shingles vaccine to protect her against painful flare-ups of varicella zoster. “Medicare patients cannot receive Tdap or zoster vaccines here. They need to obtain [them] at their pharmacy. If they receive it here, they need to pay out of pocket,” the notice read.
Fierce Healthcare
OCTOBER 26, 2023
Abridge, a startup that developed artificial intelligence-based documentation solutions for healthcare, has seen rapid growth in the past year, propelled by a "tornado of tailwinds," according to c | Abridge, a startup that developed artificial intelligence-based documentation solutions for healthcare, has seen rapid growth in the past year, propelled by a "tornado of tailwinds," according to company CEO Shivdev Rao, M.D.
Pharmacy Times
OCTOBER 27, 2023
Mirikizumab-mrkz (Omvoh; Eli Lilly and Company) is the first IL-23p19 antagonist approved for adult patients with moderately to severely active ulcerative colitis.
Drug Topics
OCTOBER 27, 2023
The awards recognize the teams, coaches, and pharmacies that have demonstrated outstanding commitment to transforming community pharmacy practice.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT
OCTOBER 25, 2023
PHILADELPHIA — Cesar de la Fuente believes the next breakthrough antibiotic might come from animals that have been dead for thousands of years. Since 2021, his lab here at the University of Pennsylvania has built algorithms to trawl genetic databases for protein fragments, called peptides, with microbe-squashing properties. They started with human DNA.
Fierce Healthcare
OCTOBER 26, 2023
Insurance coverage often fails to help Americans avoid medical debt, a new survey from the Commonwealth Fund revealed. | Even with health insurance, people are feeling the effects of high medical costs, often cutting back on necessities or delaying care. A new survey shows half of Americans struggle to avoid their healthcare.
Pharmacy Times
OCTOBER 26, 2023
With health systems undergoing a necessary reevaluation of how they allocate their funding into the future, initial data support the need for them to offer a hospital-at-home option for patients they serve.
Drug Store News
OCTOBER 27, 2023
Sheryl Burke, SVP of Corporate Social Responsibility & Chief Sustainability Officer of CVS Health, shines a light on the retailer's efforts to help communities at the local and national levels.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT
OCTOBER 24, 2023
People eligible to use the only needle-free flu vaccine available in the United States may be able, next year, to give it to themselves or to eligible children at home. AstraZeneca, which makes the vaccine FluMist, announced Tuesday it has submitted to the Food and Drug Administration a supplemental biologics license application that would allow for self-administration of the vaccine by people ages 18 through 49, and would allow people 18 and older to give the vaccine to eligible children.
Fierce Healthcare
OCTOBER 23, 2023
Two-thirds of patients receiving three months of outpatient therapy will not reach remission, a new analysis of behavioral health therapy outcomes data reveals. | Practitioners can use the framework, known as the Blueprint Quality Index (BQI), to track quality improvement over time, as well as assess the effect of programmatic or infrastructure changes on patient outcomes.
Pharmacy Times
OCTOBER 26, 2023
The hybrid pharmacy model represents a significant step forward in providing the best possible care for individuals struggling with behavioral health conditions, ultimately improving their outcomes and overall well-being.
Fierce Pharma
OCTOBER 24, 2023
In the biopharma industry, post-merger layoffs are often a question of when and how many. | In the biopharma industry, post-merger layoffs are often a question of when and how many. In the case of Amgen’s $27.8 billion buyout of Horizon, they came quickly. Around 350 former Horizon employees are being told this week that their positions will be eliminated.
STAT
OCTOBER 23, 2023
The risks of severe neonatal morbidity, neonatal death, and admission to the neonatal intensive care unit were all significantly lower during the first month of birth in infants whose mothers were vaccinated against Covid-19, and protection against the virus continued for up to six months after birth, according to a new study published Monday in JAMA Pediatrics.
Fierce Healthcare
OCTOBER 27, 2023
Older adults are adopting digital health tools at a higher rate than ever before. | At Elevance Health, we are seeing an increasing acceptance of virtual care and technology by older adults to help manage their health.
Pharmacy Times
OCTOBER 24, 2023
Nirsevimab-alip (Beyfortus; Sanofi and AstraZeneca) is a monoclonal antibody approved to prevent against respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants under 8 months of age born during or entering their first RSV season.
Fierce Pharma
OCTOBER 26, 2023
Novartis believes a former employee of its Egyptian affiliate made off with thousands of files before jumping ship to Takeda. | Novartis believes a former employee of its Egyptian affiliate made off with thousands of files before jumping ship to Takeda. Now, the Swiss pharma giant wants a peek at Takeda’s business records to find out whether its confidential information has been used improperly.
STAT
OCTOBER 24, 2023
Since the Apple Watch was unveiled in 2014, it has been trumpeted not only as a high tech fashion accessory, but also as a way for people to track their own health and fitness. It has evolved as a popular cardio tool for such uses as heart rate monitoring, recording your ECG, and measuring the oxygen saturation of your blood. But now, after nearly a decade of development, the Apple Watch is being leveraged on an entirely new health frontier: Parkinson’s disease, the degenerative brain dis
Fierce Healthcare
OCTOBER 26, 2023
A new national, multispecialty advocacy organization representing independent practices launched last week. | The American Independent Medical Practice Association says it is the first advocacy organization of its kind focused on supporting private medicine across specialties. It is made up of 5,000 physicians collectively treating 10 million U.S. patients.
Pharmacy Times
OCTOBER 24, 2023
Jack Mozloom, vice president of Public Affairs at the National Community Pharmacists Association (NCPA), speaks with Matt Seiler, general counsel at NCPA, about the current PBM litigation at the 2023 NCPA Convention.
PharmaVoice
OCTOBER 25, 2023
“They have the money,” and they’re using it to influence drug development, according to the executive director of the IQVIA Institute for Human Data Science.
STAT
OCTOBER 23, 2023
In the last two decades, Black Americans have suffered 1.63 million excess deaths compared to white Americans. Experts gathered at the STAT Summit in Boston last week to discuss the crisis of Black deaths in the U.S. and interventions that can help advance health equity. “If we continue to have a maternal health crisis, if we continue to have an infant mortality crisis … then we’re going to potentially see a situation or circumstance where Black people can be extinct in the
Fierce Healthcare
OCTOBER 27, 2023
The federal government is rolling back a pandemic-era waiver that lowered the bar for 340B hospitals to dispense discounted drugs across additional outpatient sites, a decision hospitals said will | HRSA is giving hospitals 90 days to bring any off-site, outpatient facilities using 340B drugs into compliance with requirements that had been waived during the COVID-19 pandemic.
Pharmacy Times
OCTOBER 23, 2023
Infliximab-dyyb (Zymfentra; Celltrion USA) is a subcutaneous version of Celltrion’s infliximab biosimilar for the maintenance treatment of adults with moderately to severely active ulcerative colitis and Crohn disease.
Fierce Pharma
OCTOBER 27, 2023
Sanofi acolytes are none too happy with the latest chapter of CEO Paul Hudson’s "Play to Win" strategy. | Sanofi acolytes are none too happy with the latest chapter of CEO Paul Hudson’s "Play to Win" strategy. After unveiling the pivot alongside third-quarter earnings Friday, Sanofi’s stock plunged nearly 20%, with one analyst group suggesting the plan came “at the wrong time.
STAT
OCTOBER 23, 2023
Fixing the U.S. health care system can seem like a herculean task. But the solution is “actually very simple,” according to Massachusetts Institute of Technology economist Amy Finkelstein. In their recent book “ We’ve Got You Covered: Rebooting American Health Care ,” Finkelstein and Stanford economist Liran Einav describe how years of research have led them to the conclusion that the best way forward is for the U.S. to offer universal basic health care coverag
Fierce Healthcare
OCTOBER 25, 2023
Ayble Health, a digital health platform focused on chronic gastrointestinal conditions, has unveiled a mind-gut program. | The program integrates with Ayble’s baseline nutrition program and offers evidence-based brain-gut behavioral therapy techniques including cognitive behavioral therapy, acceptance and commitment therapy and gut-directed hypnosis.
Pharmacy Times
OCTOBER 27, 2023
With a new administration protocol created specifically for the routine clinic, infectious disease physicians can treat recurrent clostridioides difficile infection in less than 3 weeks.
Fierce Pharma
OCTOBER 26, 2023
With concerns growing over the burden Leqembi could impose on healthcare infrastructure, Eisai and Biogen have trotted out data for an under-the-skin version of the Alzheimer’s disease drug that ma | Eisai and Biogen have trotted out data for a subcutaneous version of the Alzheimer’s disease drug Leqembi. The self-injected version showed an encouraging efficacy result but a seemingly increased risk of ARIA, which analysts said shouldn't be too much of a concern.
Expert insights. Personalized for you.
105 
Let's personalize your content